In CSF, YKL-40 is elevated in several acute and chronic neuroinflammatory conditions [16] and in preclinical and prodromal AD/mild cognitive impairment (MCI) [23–26], which is in agreement with the potential role of astrocytosis in early AD pathogenesis [27]. This evidence concerns the gene CHI3L1 and Alzheimer disease.